Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
217 * | Mon, 8/4/2014, 2:00 PM - 3:50 PM | CC-257B | |
The Role of Statisticians in Risk-Based Monitoring and Fraud Detection in Clinical Trials — Topic Contributed Papers | |||
Biopharmaceutical Section | |||
Organizer(s): Richard C. Zink, JMP Life Sciences, SAS Institute | |||
Chair(s): Kelci J. Miclaus, JMP Life Sciences, SAS Institute | |||
2:05 PM | Ensuring Data Quality and Identifying Potential Fraud in Clinical Trials — Nancy Geller, NIH | ||
2:25 PM | Signal Detection of Potentially Fraudulent Activity in Clinical Trials — Richard C. Zink, JMP Life Sciences, SAS Institute | ||
2:45 PM | Risk-Based Monitoring and Statisticians: An Evolving Role in Methods, Collaboration, Education, and Implementation — Rakhi Kilaru, PPD | ||
3:05 PM | The Role of Statisticians in Risk-Based Monitoring — William Lawton, Boehringer Ingelheim | ||
3:25 PM | Discussant: | ||
3:45 PM | Floor Discussion |
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.